EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency

Marijke Verhaegen, Marianne Croonenborghs, Nidhi Sorout, Andrea Sartori, Becky Provinciael, Eef Meyen, Joren Stroobants, Robin Hermans, Maarten Jacquemyn, Dirk Daelemans, Ana Lucia Rosales-Rosas, Leen Delang und 4 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Marijke Verhaegen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Dengue Virus, Endoplasmic Reticulum, SEC Translocation Channels, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, KU Leuven.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusEndoplasmic ReticulumSEC Translocation ChannelsAntiviral AgentsPolyproteinsViral ProteinsHumansVirus ReplicationAnimalsProtein TransportYellow fever virusSulfonamides

Stichwörter der Autor:innen

CP: microbiologySec61 transloconZika virusantiviralco-translational translocationcyclotriazadisulfonamidedengue virus

Substanzen

SEC Translocation ChannelsAntiviral AgentsPolyproteinsViral ProteinsSulfonamides

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
  • Center for Bioinformatics, Saarland University, 66123 Saarbrücken, Saarland, Germany.
  • Department of Food and Drug, University of Parma, 43124 Parma, Italy.
  • Centre for Structural and Cell Biology in Medicine, Institute of Biology, University of Lübeck, 23562 Lübeck, Germany.
  • Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium. Electronic address: kurt.vermeire@kuleuven.be.

Förderung

  • German Research Foundation
  • KU Leuven

Zitieren

APA

Verhaegen, M., Croonenborghs, M., Sorout, N., Sartori, A., Provinciael, B., Meyen, E., Stroobants, J., Hermans, R., Jacquemyn, M., Daelemans, D., Rosales-Rosas, A. L., Delang, L., Maes, P., Hartmann, E., Helms, V., & Vermeire, K. (2025). Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116642

Vancouver

Verhaegen M, Croonenborghs M, Sorout N, Sartori A, Provinciael B, Meyen E, et al. Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116642

BibTeX
@article{Verhaegen2025,
  author = {Verhaegen, Marijke and Croonenborghs, Marianne and Sorout, Nidhi and Sartori, Andrea and Provinciael, Becky and Meyen, Eef and Stroobants, Joren and Hermans, Robin and Jacquemyn, Maarten and Daelemans, Dirk and Rosales-Rosas, Ana Lucia and Delang, Leen and Maes, Piet and Hartmann, Enno and Helms, Volkhard and Vermeire, Kurt},
  title = {Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116642}
}
Kostenlos starten →